Albert David Ltd Falls to 52-Week Low Amid Continued Downtrend

Stock Price Movement and Market Context

On the trading day, Albert David Ltd’s stock touched an intraday low of Rs.645, representing a 5.03% decline from the previous close. This drop contributed to a three-day consecutive fall, during which the stock lost 6.25% in value. The stock’s performance notably lagged behind the Pharmaceuticals & Biotechnology sector, underperforming by 4.35% on the day.

Albert David Ltd is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum. This technical positioning underscores the stock’s vulnerability amid broader market pressures.

The broader market environment has also been challenging. The Sensex opened sharply lower at 77,056.75, down 1,862.15 points or 2.36%, and was trading at 77,135.69 by mid-session, down 2.26%. The index has experienced a three-week consecutive decline, losing 6.86% over this period. While the Sensex remains below its 50-day moving average, the 50DMA itself is positioned above the 200DMA, indicating some underlying longer-term support. Meanwhile, the INDIA VIX index hit a new 52-week high, reflecting elevated market volatility.

Financial Performance and Valuation Concerns

Albert David Ltd’s financial metrics have contributed to the subdued investor sentiment. Over the past year, the stock has delivered a negative return of 27.85%, in stark contrast to the Sensex’s positive 3.77% gain over the same period. The company’s 52-week high was Rs.959.35, highlighting the extent of the recent decline.

One of the key concerns is the company’s long-term growth trajectory. Operating profit has contracted at an annualised rate of 239.68% over the last five years, indicating significant erosion in profitability. Additionally, the company’s profits have fallen by 76.2% in the past year, further weighing on valuation.

The stock’s risk profile is elevated, with a Mojo Score of 31.0 and a Mojo Grade of Sell, downgraded from a previous Strong Sell rating on 14 May 2025. The Market Cap Grade stands at 4, reflecting modest market capitalisation relative to peers. The company’s earnings before depreciation, interest, and taxes (EBITDA) remain negative, which adds to concerns about financial stability.

Recent Quarterly Results and Shareholding

Despite the overall negative trend, Albert David Ltd reported positive quarterly results in December 2025 after four consecutive quarters of negative performance. The company recorded its highest quarterly net sales at Rs.89.93 crores and a PBDIT of Rs.10.82 crores. The operating profit to net sales ratio also reached a peak of 12.03% during this quarter, indicating some improvement in operational efficiency.

The company maintains a low average debt-to-equity ratio of zero, suggesting a conservative capital structure with limited leverage. Promoters remain the majority shareholders, maintaining significant control over the company’s strategic direction.

Comparative Performance and Sector Positioning

Albert David Ltd’s performance has been below par not only in the near term but also over longer horizons. The stock has underperformed the BSE500 index over the last three years, one year, and three months. This persistent underperformance highlights challenges in maintaining competitive positioning within the Pharmaceuticals & Biotechnology sector.

The stock’s current valuation appears risky when compared to its historical averages, reflecting market concerns about growth prospects and profitability sustainability. The ongoing decline to a 52-week low of Rs.645 underscores the cautious stance adopted by market participants.

Summary of Key Metrics

To summarise, Albert David Ltd’s stock has reached a new 52-week low of Rs.645, reflecting a sustained downtrend amid broader market weakness and sector underperformance. The stock’s three-day consecutive decline and positioning below all major moving averages highlight ongoing selling pressure.

Financially, the company faces challenges with a significant contraction in operating profit over five years, a 76.2% drop in profits over the past year, and negative EBITDA. However, the recent quarterly results in December 2025 showed some improvement in sales and operating margins, albeit within a difficult overall context.

The company’s low debt levels and promoter majority shareholding remain notable features, but these have not been sufficient to arrest the stock’s decline. The stock’s Mojo Grade of Sell and a Mojo Score of 31.0 reflect the cautious market view.

Market and Sector Environment

The broader market environment has been volatile, with the Sensex experiencing a three-week losing streak and elevated volatility as indicated by the INDIA VIX reaching a 52-week high. The Pharmaceuticals & Biotechnology sector has also faced headwinds, contributing to Albert David Ltd’s relative underperformance.

Conclusion

Albert David Ltd’s fall to a 52-week low of Rs.645 on 9 March 2026 encapsulates a period of sustained challenges for the company and its stock. The combination of weak financial performance, valuation concerns, and adverse market conditions has culminated in this significant price level. While recent quarterly results showed some positive signs, the overall trend remains subdued as reflected in the stock’s technical and fundamental indicators.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today